# Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma

> **NCT00504257** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 45 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Malignant Tumor of Peritoneum

## Interventions

- **DRUG:** Avastin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00504257
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2014-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504257, "Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00504257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*